Methapharm Inc. is recalling 5,377 cartons of Pantoprazole sodium for Injection (40 mg/vial), a medication used to treat conditions involving excess stomach acid. The recall was issued because certain lots were inadvertently placed into saleable inventory in violation of approved manufacturing procedures (CGMP deviations). No injuries or incidents have been reported in connection with this product, which was distributed to hospitals, clinics, and pharmacies.
Products released into inventory outside of approved procedures may not meet quality and safety standards. While no specific harm has been reported, deviations from manufacturing protocols pose a potential risk to patients receiving the injection.
Quantity: 5377 cartons
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.